Volume : 09, Issue : 11, November – 2022
Title:
02.MUCORMYCOSIS {BLACK FUNGUS}
Authors :
Patil Rohit Prataprao, Mohammad Awais , Nazeer Ahmed, Mr. Momin Sanaurrahman
Abstract :
The fungus Mucorales causes a condition known as mucormycosis, which is an angio invasive infection. Although it is an uncommon condition, it is becoming more prevalent in those with immune impairment or poorly controlled diabetes mellitus. Even if vigorous therapy is administered, an overall higher death rate is recorded for the Rhino-orbito-cerebral, cutaneous, dissemination, intestinal, and pulmonary kinds. This review’s primary goals and objectives were to provide a summary of mucormycotic disease, its etiopathogenesis, the mortality rate of rhino cerebral mucormycosis, and new developments in therapeutic and diagnostic approaches.
Cite This Article:
Please cite this article in press Patil Rohit Prataprao et al, Mucormycosis {Black Fungus}., Indo Am. J. P. Sci, 2022; 09(11).
Number of Downloads : 10
References:
1. Mehta and Abha Pandey https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599039/
2. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clinical Infectious Diseases, 2012.
3. Infections Published: 15th May 2021 03w05 AM by Indian express news https://www.newindianexpress.com/nation/2021/ may/15/icmr-adviseson-how-to-fightmucormycosis-or-blackfungus-2302672.html
4. Wikipedia . https://en.wikipedia.org/wiki/Mucormycosis
5. Lewis RE, Kontoyiannis DP. Epidemiology and treatment of mucormycosis. Future Microbiol. Sep 2013. https:// www.ncbi.nlm.nih.gov/books/NBK544364/
6. Chamilos G, Marom EM, Lewis RE, Lionakis MS, Kontoyiannis DP. Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin. Infect. Dis., 2005.
7. https://indianexpress.com/article/explained/mucormycosis-incovidpatients-fungal-infections-7308721/
8. Farmakiotis D, Kontoyiannis DP. Mucormycoses. Infect Dis Clin North Am. Mar 2016.
9. Apollo Pulmonologist May 11, 2021. https:// healthlibrary.askapollo.com/all-about-black-fungus-ormucormycosis-incovid-19-patients/
10. Binder U, Maurer E, Lass-Flörl C. Mucormycosis–from the pathogens to the disease. Clin Microbiol Infect. 2014 Jun;20 , Article Author , Jorge L. Hernández1; Clifford J. Buckley 3.infections Published: 15th May 2021 03×05 AM by Indian express news https://www.newindianexpress.com/nation/2021/ may/15/icmr-adviseson-how-to-fightmucormycosis-or-black- fungus-2302672.html
11. 11.Ribes JA, Vanover Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2002;13:236–301. 2
12. Andrews DR, Allan A, Larbalestier RI. Tracheal mucormycosis. Ann Thorac Surg 1997;63:230–2.
13. Chamilos G, Lewis RE, Kontoyiannis DP. Lovastatin has significant activity against Zygomycetes and interacts synergistically with voriconazole. Antimicrobe Agents Chemother 2006;50:96–103.
14. Bauer H, Flanagan JF, Sheldon WH. The effects of metabolic alterations on experimental Rhizopus oryzae (mucormycosis) infections. Yale J Biol Med 1956;29:23–32.
15. Hibbett DS, Binder M, Bischoff JF. A higher-level phylogenetic classification of the fungi. Mycol Res 2007;111:509–47.
16. Song Y, Qiao J, Giovanni G, Liu G, Yang H, Wu J, et al. Mucormycosis in renal transplant recipients: a review of 174 reported cases external icon. BMC Infect Dis 2017;17:283.
17. Abdalla A, Adelmann D, Fahal A, Verbrugh H, Van Belkum A, De Hoog S. Environmental occurrence of Madurella mycetomatis, the major agent of human eumycetoma in sudan external icon.
18. Abramowitz I. Fatal perforations of the stomach due to mucormycosis of the gastrointestinal tract. S Afr Med J 1964;38:93–4.
19. Spellberg B, Edwards Jr J, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and external management icon. Clin Microbiol Rev 2005;18:556-69.
20. Voigt K, Cigelnik E, O’Donnell K. Phylogeny and PCR identification of clinically important zygomycetes based on nuclear ribosomal DNA sequence data. J Clin Microbiol 1999;37:3957–64
21. Voigt K, Wostemeyer J. Phylogeny and origin of 82 zygomycetes from all 54 genera of the mucorales and mortierellales based on combined analysis of actin and translation elongation factor EF-1alpha genes. Gene 2001;270:113–20
22. . Dannaoui E, Garcia Hermoso D. The zygomycetes. In: Kavanagh K. ed. New insights in medical mycology. Springer: New York; 2007. p. 159–83.
23. Sugar A. Agents of mucormycosis and related species. In: Mandell GL, Bennett JE, Dolin R. eds. Principles and practice of infectious diseases. 6th edn. New York: Elsevier; 2005. p. 2973– 84.
24. 24.Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosisexternal icon. Clin Infect Dis 2012;54:23-34.
25. James TY, Kauff F, Schoch CL. Reconstructing the early evolution of Fungi using a six-gene phylogeny. Nature 2006;443:818–22.
26. Marty FM, Cosimi LA, Baden LR. Breakthrough mucormycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med 2004;350:950–2.
27. Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect 2004;10:31–47.
28. Andrews PA, Abbs IA, Koffman CG, Ogg CS, Williams DG. Mucormycosis in transplant recipients: possible case transmission and potentiation by cytomegalovirus. Nephrol Dial Transplant 1994;9:1194–6.
29. Talmi YP, Goldschmied Reouven A, Bakon M. Rhino-orbital and rhino-orbito-cerebral mucormycosis. Otolaryngol Head Neck Surg 2002;127:22–31.
30. Anand VK, Alemar G, Griswold JA. Intracranial complications of mucormycosis: an experimental model and clinical review. Laryngoscope 1992;102:656–62.
31. Lass Florl C. Zygomycosis: conventional laboratory diagnosis. Clin Microbiol Infect 2009;15:60–5.